A New Prostate Cancer Screening Recommendation

The US Preventive Services Task Force (USPSTF) recommendation statement for screening for prostate cancer, supported by the evidence report, has been updated to a grade C recommendation, from the grade D recommendation of the 2012 statement, regarding prostate-specific antigen (PSA)-based screening. In 2012, the USPSTF recommended against PSA-based screening for prostate cancer, but now the Task Force concludes that "for men aged 55 to 69 years, the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one." (For men 70 years or older, the Task Force maintains its D recommendation for PSA-based prostate cancer screening.) After the 2012 USPSTF recommendation and prior to this updated statement, other groups had responded to the complexity of the prostate cancer screening decision with additional recommendations. For example, in 2013, the American Urologic Association recommended a shared decision-making approach to prostate cancer screening for men aged 55 to 69 years, and the American College of Physicians also recommended a screening approach incorporating patient preferences for men aged 50 to 69 years, with both organizations recommending against screening in men 70 years or older or with life expectancy less than 10 to 15 years. However, even with these recommendations, shared decision making for prostate cancer screening overall has not significantly increased.

https://ift.tt/2K1K2Rs